699
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

General practitioners’ adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark

, , , &
Pages 47-54 | Received 11 Mar 2009, Accepted 11 Sep 2009, Published online: 20 Nov 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Petra G. van Peet, Jacobijn Gussekloo, Wendy P.J. den Elzen, Jeanet W. Blom, Margot W.M. de Waal & Wouter de Ruijter. (2015) Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?. Scandinavian Journal of Primary Health Care 33:4, pages 260-268.
Read now
Jørgen Nexøe. (2012) Too much health care and too little care for the sick?. Scandinavian Journal of Primary Health Care 30:2, pages 62-63.
Read now
Lise Graversen, Bo Christensen, Knut Borch-Johnsen, Torsten Lauritzen & Annelli Sandbaek. (2011) Lipid-lowering drugs as primary prevention in general practice: Do patients reach guideline goals and continue treatment? ADDITION Denmark. Scandinavian Journal of Primary Health Care 29:4, pages 216-221.
Read now
Maisa Kuusela, Anna-Liisa Koivisto, Paula Vainiomäki, Tero Vahlberg & Päivi Rautava. (2011) The medico-professional quality of GP consultations assessed by analysing patient records. Scandinavian Journal of Primary Health Care 29:4, pages 222-226.
Read now

Articles from other publishers (11)

Laura Inglin, Piia Lavikainen, Kari Jalkanen & Tiina Laatikainen. (2021) LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model. Scientific Reports 11:1.
Crossref
Féaron C. Cassidy, Sinead Lafferty & Cynthia M. Coleman. 2021. Type 2 Diabetes - From Pathophysiology to Cyber Systems. Type 2 Diabetes - From Pathophysiology to Cyber Systems.
Rebecca K. Simmons, Simon J. Griffin, Daniel R. Witte, Knut Borch-Johnsen, Torsten Lauritzen & Annelli Sandbæk. (2017) Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults. Diabetologia 60:11, pages 2183-2191.
Crossref
Benedicte Lind Barfoed, Dorte Ejg Jarbøl, Maja Skov Paulsen, Palle Mark Christensen, Peder Andreas Halvorsen, Jesper Bo Nielsen & Jens Søndergaard. (2015) GPs’ Perceptions of Cardiovascular Risk and Views on Patient Compliance: A Qualitative Interview Study. International Journal of Family Medicine 2015, pages 1-7.
Crossref
Charlotte Gry Harmsen, Ivar Sønbø Kristiansen, Pia Veldt Larsen, Jørgen Nexøe, Henrik Støvring, Dorte Gyrd-Hansen, Jesper Bo Nielsen, Adrian Edwards & Dorte Ejg Jarbøl. (2014) Communicating risk using absolute risk reduction or prolongation of life formats: cluster-randomised trial in general practice. British Journal of General Practice 64:621, pages e199-e207.
Crossref
Torsten Lauritzen, Knut Borch-Johnsen, Melanie J Davies, Kamlesh Khunti, Guy EHM Rutten, Annelli Sandbæk, Rebecca K Simmons, Maureen van den Donk, Nicholas J Wareham & Simon J Griffin. (2013) Screening for diabetes: what do the results of the ADDITION trial mean for clinical practice?. Diabetes Management 3:5, pages 367-378.
Crossref
Tomasz Tomasik, Adam Windak, Bohumil Seifert, Janko Kersnik, Malgorzata Palka, Grzegorz Margas & Byma Svatopluk. (2013) The self-perceived role of general practitioners in care of patients with cardiovascular diseases. A survey in Central and Eastern European countries following health care reforms. International Journal of Cardiology 164:3, pages 327-333.
Crossref
Heike U Krämer, Elke Raum, Gernot Rüter, Ben Schöttker, Dietrich Rothenbacher, Thomas Rosemann, Joachim Szecsenyi & Hermann Brenner. (2012) Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study. Cardiovascular Diabetology 11:1.
Crossref
Torsten Lauritzen, Annelli Sandbaek, Anders Helles Carlsen & Knut Borch-Johnsen. (2012) All-cause mortality and pharmacological treatment intensity following a high risk screening program for diabetes. A 6.6 year follow-up of the ADDITION study, Denmark. Primary Care Diabetes 6:3, pages 193-200.
Crossref
T. Lauritzen, A. Sandbaek, M. V. Skriver & K. Borch-Johnsen. (2011) HbA1c and cardiovascular risk score identify people who may benefit from preventive interventions: a 7 year follow-up of a high-risk screening programme for diabetes in primary care (ADDITION), Denmark. Diabetologia 54:6, pages 1318-1326.
Crossref
Pia Kirkegaard, Adrian GK Edwards, Bo Hansen, Mette D Hansen, Morten SA Jensen, Torsten Lauritzen, Mette B Risoer & Janus L Thomsen. (2010) The RISAP-study: a complex intervention in risk communication and shared decision-making in general practice. BMC Family Practice 11:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.